ImmuCell (ICCC) had the highest return in March 1991 by a US stock in the Biotechnology Industry, returning 142.4%.
| ASSET | MONTH | % RETURN |
|---|---|---|
ImmuCell (ICCC) | March 1991 | 142.44% |
Celldex Therapeutics (CLDX) | March 1991 | 55.26% |
Amgen (AMGN) | March 1991 | 37.97% |
GT Biopharma (GTBP) | March 1991 | 30.43% |
Compass Therapeutics (CMPX) | March 1991 | 26.67% |
Insmed (INSM) | March 1991 | 21.43% |
Anixa Biosciences (ANIX) | March 1991 | 20.9% |
Heron Therapeuti (HRTX) | March 1991 | 19.23% |
CEL-SCI (CVM) | March 1991 | 11.11% |
Lisata Therapeutics (LSTA) | March 1991 | 0% |
XOMA (XOMA) | March 1991 | -4.17% |
Vera Therapeutics (VERA) | March 1991 | -4.88% |
Abeona Therapeutics (ABEO) | March 1991 | -6.34% |
